1. Home
  2. ZJYL vs POM Comparison

ZJYL vs POM Comparison

Compare ZJYL & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JIN MEDICAL INTERNATIONAL LTD.

ZJYL

JIN MEDICAL INTERNATIONAL LTD.

HOLD

Current Price

$0.16

Market Cap

32.7M

ML Signal

HOLD

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$0.24

Market Cap

38.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
ZJYL
POM
Founded
2006
2015
Country
China
China
Employees
N/A
N/A
Industry
Industrial Specialties
Other Specialty Stores
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
38.8M
IPO Year
2023
2025

Fundamental Metrics

Financial Performance
Metric
ZJYL
POM
Price
$0.16
$0.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
489.8K
Earning Date
08-20-2025
12-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$22,826,624.00
$51,210,721.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.19
N/A
Revenue Growth
13.42
12.13
52 Week Low
$0.11
$0.25
52 Week High
$1.03
$6.43

Technical Indicators

Market Signals
Indicator
ZJYL
POM
Relative Strength Index (RSI) 39.35 24.58
Support Level $0.12 $0.28
Resistance Level $0.18 $0.32
Average True Range (ATR) 0.03 0.03
MACD -0.00 0.12
Stochastic Oscillator 30.12 9.83

Price Performance

Historical Comparison
ZJYL
POM

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: